Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory ...

(Reuters) -French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio ...

Human metapneumovirus doesn’t account for all the unknown viruses, but it’s a significant proportion – about as many cases as RSV or influenza. But no one knows about it.

The Centers for Disease Control and Prevention said human metapneumovirus – also known as HMPV – filled intensive care units with children and seniors this spring.

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

Like many winter viruses, human metapneumovirus or hMPV is an infection that affects the upper and respiratory tract, according to the CDC.

"Human metapneumovirus doesn't account for all the unknown viruses, but it's a significant proportion — about as many cases as RSV or influenza." So a person may have had the disease without ...

This spring has been kind of a meta experience. This isn’t referring to the owner of Facebook. No, there’s been a surge of the human metapneumovirus (HMPV). In fact, in mid-March, at the ...

Read: Cases of human metapneumovirus surge; What are the signs, symptoms of HMPV? 3. Just like RSV and the flu, HMPV can cause people to be admitted to intensive care units and can cause deadly ...

Human metapneumovirus is a respiratory virus that mainly infects children, the elderly, and people with compromised immune systems. It frequently resembles symptoms of the typical cold or flu ...

It's called human metapneumovirus (HMPV). "The symptoms are identical almost to influenza and respiratory syncytial virus," said Dr. Jorge Rodriguez, a board-certified internal medicine specialist.

Officials in India have confirmed the country's first seven cases of human metapneumovirus, or HMPV, which is reportedly surging in neighboring China. Jan 7 ...